From: bcl-2 expression is not associated with survival in metastatic cutaneous melanoma: A historical cohort study
bcl-2 positive (%)
bcl-2 negative (%)
Total (%)
Lymph node
26 (74.3)
9 (25.7)
35 (100)
Subcutaneous
24 (85.7)
4 (14.3)
28 (100)
Visceral
14 (82.3)
3 (17.7)
17 (100)
Total
64 (80.0)
16 (20.0)
80 (100)